Sulindac
Product Images NDC 52959-195

2 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 52959-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formulas Of Sulindac And Its Metabolites (Sulindac 1)

Structural Formulas Of Sulindac And Its Metabolites (Sulindac 1)
Chemical structure diagram illustrating the metabolic conversion of Sulindac through its sulfoxide and sulfone forms, showing structural changes in the molecule with chemical groups labeled.*
FDA Label Image

Ndc 0591-5660-01sulindactablets Usp200 mg100 Tablets Rx Only (Sulindac 3)

Ndc 0591-5660-01sulindactablets Usp200 mg100 Tablets Rx Only (Sulindac 3)
Label for Sulindac 200 mg tablet with NDC 52959-195-60, manufactured by Watson Lab, India, and labeled by H.J. Harkins Company, Inc. The label includes lot number SU200WL, expiration date 01/12, and a note to compare to Clinoril. It contains yellow capsules with a quantity of 60 tablets. The label also carries a prescription warning and dosing direction to follow doctor instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.